Westend Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Westend Capital Management's AMGN Position: Q1 2025 in Review
Westend Capital Management sold out of Amgen (AMGN) in Q1 2025, closing a stake of 27 shares — an estimated $7.04K sold.
Westend Capital Management first reported a position in AMGN in Q3 2024 and held it in 2 quarters. The position peaked at $8.7K in Q3 2024. 2,927 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.
- Westend Capital Management reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
- Westend Capital Management sold 27 Amgen shares in Q1 2025, an estimated $7.04K.
- Westend Capital Management first reported a position in Amgen in Q3 2024 and held it in 2 quarters.
- Westend Capital Management's Amgen position peaked at $8.7K in Q3 2024.
- 2,927 funds tracked by Wall St. Rank held Amgen as of Q1 2025.
Based on Westend Capital Management's 13F filing for Q1 2025, filed 24 Apr 2025.